“…10 shows a summary of the comparative results. Note that none of the algorithms that presented in Table XI (MEPGANf1-f3 [12], MLP-BP [13], ISO-FLANN [13], NN-CAPSO [14], NN-GSA [14], NN-ICA [14], NN-BP [15], NN-MVO [15], MODE-ESNN [16], DPM [16], SAE-MR Over all, NN-GSO algorithm is better or at least competitive for breast cancer, diabetes, heart, hepatitis, appendicitis and Alzheimer. On the other hand, NN-GSO performs comparable for the liver, disorders, thyroid and dermatology datasets (with respect to classification accuracy) comparing to other algorithms.…”